查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2016987

手術罩衣市場：2026-2032年全球市場預測（依產品類型、無菌狀態、材料、防護等級、應用、最終用戶及通路分類）

Surgical Gown Market by Product Type, Sterility, Material, Protection Level, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，手術罩衣市場價值將達到 15.5 億美元，到 2026 年將成長到 16.3 億美元，到 2032 年將達到 21.9 億美元，複合年成長率為 4.98%。

主要市場統計數據
基準年 2025 15.5億美元
預計年份：2026年 16.3億美元
預測年份 2032 21.9億美元
複合年成長率 (%) 4.98%

全面介紹不斷變化的安全、監管和採購趨勢，同時將手術罩衣定位為一項重要的臨床安全措施。

手術罩衣在維持侵入性手術過程中的臨床無菌環境、保護手術團隊以及保障患者預後方面發揮核心作用。材料科學的進步、感染預防方案的完善以及法律規範，使得罩衣不再只是基本的防護衣，而是成為手術全期風險管理的關鍵組成部分。因此，罩衣的採購決策與臨床績效指標、職業安全標準以及供應鏈連續性計畫之間的關聯也日益緊密。

臨床期望、材料創新、更嚴格的法規和供應鏈韌性如何共同作用，重新定義手術罩衣的設計、採購和生命週期的決策。

手術罩衣領域正經歷一場變革，其驅動力來自臨床需求、製造製程創新和供應鏈韌性等多面向因素。不織布和複合材料層壓技術的創新，使得新型材料在防護性能和透氣性之間實現了平衡，從而能夠延長連續穿著時間而不影響防護效果。同時，縫紉工藝、合身設計和人體工學設計的進步，正在減輕醫護人員的疲勞，提高他們的手部靈活性，進而推動這些產品在高度專業化的醫療領域中廣泛應用。

評估近期關稅措施對籌資策略、供應商本地化以及罩衣供應總成本和連續性的多方面影響。

近期關稅調整為購買手術罩衣及相關防護衣的機構帶來了新的成本和採購方面的考量。關稅上漲增加了接收成本，迫使採購者考慮其他供應商、替代材料或不同的分銷管道，從而給採購預算帶來壓力，並減輕財務影響。實際上，這些趨勢正在重塑談判優勢、合約結構和總擁有成本 (TCO) 的計算方式。

關鍵細分分析解釋了產品類型、無菌狀態、材料化學特性、防護等級、應用、最終用戶和分銷管道趨勢如何影響採購和臨床選擇。

細分市場分析揭示了個體設計特徵和使用模式如何影響臨床選擇和籌資策略。從「一次性」與「可重複使用」的角度考慮產品類型時，採購負責人會權衡一次性產品的便利性和監管影響，以及可重複使用紡織品系統（需要洗滌和消毒設施）帶來的環境和生命週期影響。同樣，根據手術風險等級對罩衣手術罩衣進行分類，也會影響選擇標準，無菌罩衣服用於需要無菌屏障的手術。

採購框架、管理體制和製造地的區域差異如何影響罩衣的選擇、供應商策略和臨床部署模式。

區域趨勢，無論跨越哪個大洲，都對採購選擇、監管合規和供應商策略產生重大影響。在美洲，採購往往由大規模綜合醫療保健系統和集團採購組織主導，這些機構要求提供檢驗的績效數據、可靠的供應連續性和清晰的監管文件。在這種環境下，能夠提供穩定品質、快速交貨以及諸如臨床教育和現場測試支援等附加價值服務的供應商具有顯著優勢。

對競爭格局和供應商環境的分析揭示了產品創新、規模經濟和服務整合如何決定採購選擇和長期夥伴關係。

主要製造商和經銷商之間的競爭格局呈現出創新主導差異化、規模成本競爭以及服務導向價值提案的特徵。專注於增強防護功能、人體工學設計和永續材料的產品研發的新參與企業往往能獲得臨床醫生和安全委員會的支持。同時，大規模製造商則利用其供應鏈的連續性和廣泛的分銷網路，為大型醫療機構和集團採購組織提供服務。

為製造商、採購負責人和臨床領導者提供實用建議，以平衡手術罩衣的創新、採購彈性和生命週期管理。

為維持韌性並持續滿足臨床需求，產業領導者應採取多管齊下的策略，平衡創新、供應鏈連續性和生命週期管理。首先，投資於產品研發，優先考慮已驗證的防護性能、符合人體工學的貼合度以及能夠減少環境影響且不影響臨床防護的材料選擇。其次，實現生產和採購地點的多元化，納入區域生產能力和經認證的二級供應商，從而降低與地緣政治和關稅波動相關的業務風險。

採用透明的混合方法研究途徑，結合一手訪談、標準審查和情境測試，以檢驗臨床和供應鏈的見解。

本研究的綜合結果是基於一種混合調查方法結合了第一手和第二手調查、嚴謹的文獻審查以及與臨床和供應鏈相關人員的交叉檢驗。主要資訊來源包括對採購經理、消毒經理、各外科專科的臨床負責人以及生產品質經理的結構化訪談，從而直接了解規格決定因素、評估方案和物流限制。這些討論反映在對產品採用趨勢、臨床可用性問題和供應商績效特徵的定性評估中。

策略結論強調了臨床、營運和永續性的綜合影響，這些影響應指南未來的罩衣採購和產品開發。

總之，手術罩衣正超越其作為一次性防護服的傳統角色，發展成為兼顧臨床安全、營運韌性和環境管理的策略性重要產品。材料創新、更嚴格的監管要求以及供應鏈重組正在影響採購標準和臨床醫生的偏好。因此，各機構必須採用綜合方法選擇罩衣，此方法需整合防護性能、使用者舒適度、生命週期影響及供應商可靠性等因素。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 手術罩衣市場：依產品類型分類

  • 一次性的
  • 可重複使用的

第9章：以滅菌狀態分類的手術罩衣市場

  • 非無菌
  • 已滅菌

第10章：手術罩衣市場：依材料分類

  • 滌棉混紡
  • 聚乙烯塗層聚丙烯
  • 紡粘聚丙烯
  • 紡粘、熔噴、紡粘

第11章：以防護等級分類的手術罩衣市場

  • 一級（最低風險）
  • 2級（低風險）
  • 3級（中度風險）
  • 4級（高風險）

第12章 手術罩衣市場：依應用領域分類

  • 循環系統
  • 一般外科
  • 整形外科

第13章 手術罩衣市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第14章 手術罩衣市場：依通路分類

  • 離線
  • 線上

第15章 手術罩衣市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 手術罩衣市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 手術罩衣市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國手術罩衣市場

第19章：中國手術罩衣市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3M Company
  • Ahlstrom-Munksjo Oyj
  • ANSELL LTD
  • B. Braun SE
  • Cardinal Health, Inc.
  • Delta Med SpA
  • Dispotech srl
  • DuPont de Nemours, Inc.
  • Halyard Health, Inc. by Owens & Minor Inc.
  • Kimberly-Clark Corporation
  • Lohmann & Rauscher GmbH & Co. KG
  • Medica Europe BV
  • Medline Industries, Inc.
  • Molnlycke Health Care AB
  • Paul Hartmann AG
  • PRIMED Medical Products Inc.
  • Priontex（Pty）Ltd
  • Sara Health Care Pvt Ltd
  • Shanghai Medical Corporation
  • Steris Corporation
  • Thermo Fisher Scientific Inc.
  • TIDI Products, LLC
  • Winner Medical Co., Ltd.
  • Zhejiang Runtai Automation Technology Co.,Ltd.
Product Code: MRR-034B50030986

The Surgical Gown Market was valued at USD 1.55 billion in 2025 and is projected to grow to USD 1.63 billion in 2026, with a CAGR of 4.98%, reaching USD 2.19 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.55 billion
Estimated Year [2026] USD 1.63 billion
Forecast Year [2032] USD 2.19 billion
CAGR (%) 4.98%

A comprehensive introduction that situates surgical gowns as vital clinical safeguards while framing evolving safety, regulatory, and procurement dynamics

Surgical gowns occupy a central role in maintaining clinical sterility, protecting surgical teams, and safeguarding patient outcomes during invasive procedures. Advances in material science, infection prevention protocols, and regulatory oversight have elevated the gown from a basic protective garment to a critical component of perioperative risk management. As such, procurement decisions about gowns increasingly intersect with clinical performance metrics, occupational safety standards, and supply chain continuity planning.

Over time, the interplay between clinical evidence, standards-setting bodies, and manufacturing capabilities has driven incremental improvements in barrier performance, wearer comfort, and environmental sustainability. These developments influence clinician preference, acquisition criteria, and the operational calculus of operating theater scheduling and throughput. Consequently, understanding the product landscape and the forces shaping design, adoption, and distribution is essential for hospital administrators, procurement leads, and product developers who aim to align gown choices with safety objectives and cost realities.

This executive synthesis frames the salient drivers and pressures reshaping gown selection and supply dynamics, highlights segmentation and regional differentials, summarizes the implications of recent tariff actions, and offers practical recommendations for stakeholders seeking to navigate an evolving regulatory and commercial environment. The objective is to equip leaders with concise, actionable insight that supports informed decisions across clinical, procurement, and strategic planning horizons.

How clinical expectations, material innovation, regulatory tightening, and supply chain resilience are jointly redefining surgical gown design, procurement, and lifecycle decisions

The surgical gown landscape is undergoing transformative shifts driven by converging forces in clinical expectations, manufacturing innovation, and supply chain resilience. Innovations in nonwoven technologies and composite laminates have yielded materials that balance barrier performance with breathability, enabling longer continuous wear times without compromising protection. Simultaneously, advances in seam construction, fit engineering, and design ergonomics are reducing clinician fatigue and improving dexterity, which in turn influences product adoption in high-acuity specialties.

Regulatory and standards changes are raising the bar for how barrier efficacy and fluid resistance are tested and communicated, prompting manufacturers to invest in higher-fidelity testing and more transparent performance claims. At the same time, increased scrutiny of environmental impact and end-of-life disposal is provoking greater interest in reusable solutions and recyclable material systems, although reusable options require investment in laundering infrastructure and chain-of-custody controls.

Supply chain dynamics are also shifting from just-in-time commoditization to a hybrid resilience model that prioritizes diversified sourcing, nearshoring, and inventory buffering. Health systems are placing greater emphasis on supplier qualification, contingency planning, and contractual terms that ensure continuity of supply during geopolitical disruptions or demand spikes. Taken together, these transformative shifts are compelling stakeholders to reassess procurement criteria, clinical evaluation workflows, and long-term vendor partnerships in pursuit of both continuity and clinical performance.

Assessing the multifaceted consequences of recent tariff actions on procurement strategy, supplier localization, and the total cost and continuity of gown supply

Recent tariff adjustments have introduced new cost and sourcing considerations for organizations that procure surgical gowns and associated protective apparel. Tariffs exert pressure on procurement budgets by increasing landed costs and incentivizing buyers to explore alternative suppliers, substitute materials, or different distribution channels in order to mitigate financial impacts. In practice, these dynamics reshape negotiation leverage, contract structures, and total cost of ownership calculations.

Beyond direct cost implications, tariff-driven shifts often accelerate supplier diversification and regional sourcing strategies, as purchasers seek to reduce exposure to tariff volatility and associated logistics constraints. For manufacturers, tariffs can prompt reassessment of manufacturing footprints, including investments in regional production capacity, strategic partnerships with local converters, and changes in supply agreements to preserve competitiveness. Such responses have downstream implications for lead times, quality control, and the stability of long-term supply relationships.

Additionally, the cumulative effect of tariff measures tends to highlight the value of transparency in the supply chain. Buyers place greater emphasis on supplier traceability, certificates of conformity, and contractual protections that address tariff pass-through and cost-sharing mechanisms. Clinically, stakeholders must balance cost containment with uncompromised barrier performance and regulatory compliance, ensuring that tariff mitigation strategies do not introduce unacceptable clinical risk. Ultimately, tariffs act as a catalyst for structural changes in sourcing behaviors, contract terms, and manufacturing localization decisions that extend beyond immediate price impacts.

Key segmentation intelligence that explains how product type, sterility, material chemistry, protection level, application, end user, and channel dynamics drive procurement and clinical selection

Segmentation reveals how distinct design attributes and use contexts shape clinical choice and procurement strategies. When product type is examined through the lens of disposable and reusable offerings, purchasers weigh single-use convenience and regulatory simplicity against the environmental and lifecycle implications that accompany reusable textile systems, which demand laundering and sterilization infrastructure. Similarly, sterility classification between non-sterile and sterile gowns guides selection criteria for procedure risk profiles, with sterile gowns reserved for surgeries where aseptic barriers are essential.

Material composition further differentiates performance and usability: polyester-cotton blends deliver durability and comfort for laundered reusables, polyethylene-coated polypropylene offers a more traditional laminated barrier, spunbond polypropylene provides basic barrier protection with enhanced cost-effectiveness, and spunbond-meltblown-spunbond constructions elevate particulate and fluid resistance for higher-risk environments. Protection level distinctions-ranging from Level 1 minimal risk through Level 4 high-risk-drive product placement within procedural protocols, influencing which gown constructions are acceptable for cardiovascular, general surgery, or orthopedic applications.

Application-specific needs introduce another layer of segmentation, as cardiovascular procedures often demand the highest barrier integrity and seam performance, whereas general surgery may prioritize a balance of protection and mobility. Orthopedic settings place a premium on durability and fluid repellency given the nature of the procedures. End-user environments such as ambulatory surgical centers, clinics, and hospitals exhibit different procurement profiles: ambulatory centers frequently favor cost-efficiency and streamlined logistics, clinics may require lighter protection for outpatient procedures, and hospitals typically mandate a broader range of gown types to cover diverse surgical specialties. Distribution channels, whether offline through traditional medical suppliers and group purchasing organizations or online via digital platforms, further shape lead times, pricing transparency, and the ability to access niche or premium products. Together, these segmentation dimensions inform specification development, clinical evaluation processes, and supplier selection criteria.

How geographic variations in procurement frameworks, regulatory regimes, and manufacturing footprints shape gown selection, supplier strategies, and clinical adoption patterns

Regional dynamics materially influence procurement choices, regulatory compliance, and supplier strategies across continents. In the Americas, procurement tends to be driven by large integrated health systems and group purchasing organizations that demand validated performance data, reliable supply continuity, and clear regulatory documentation. This environment favors suppliers that can provide consistent quality, rapid fulfillment, and integrated value services such as clinical education and on-site trial support.

In Europe, Middle East & Africa, regulatory harmonization efforts coexist with varied national procurement frameworks, resulting in a patchwork of requirements that suppliers must navigate. Buyers in these regions balance centralized hospital procurement with national and local purchasing preferences, and there is growing interest in reusable systems driven by sustainability mandates and cost containment initiatives. As a result, suppliers often tailor product portfolios and support services to meet both regulatory expectations and localized operational constraints.

Across Asia-Pacific, rapid expansion of healthcare infrastructure, increasing surgical volumes, and investments in regional manufacturing capacity are reshaping supplier landscapes. Many countries in the region pursue nearshoring strategies to reduce lead times and manage currency and tariff risk, while also fostering domestic production capabilities. Consequently, buyers encounter a broadened supplier set with varied price-performance trade-offs, and manufacturers are responding by investing in localized quality assurance and regulatory compliance processes. These regional differentials underscore the importance of aligning sourcing strategies with local regulatory regimes, logistics realities, and clinical practice patterns.

Competitive and supplier landscape analysis highlighting how product innovation, scale advantages, and service integration determine procurement preference and long-term partnerships

Competitive dynamics among leading manufacturers and distributors are characterized by a mix of innovation-driven differentiation, scale-based cost competition, and service-oriented value propositions. Market participants that invest in product development-focusing on barrier enhancement, ergonomic design, and sustainable materials-tend to capture preference among clinician champions and safety committees, while large-scale manufacturers leverage supply continuity and distribution breadth to serve major institutional buyers and group purchasing organizations.

Partnerships between gown producers and service providers, including sterile processing organizations and specialty distributors, create integrated offerings that simplify implementation for hospital systems and ambulatory centers. At the same time, a proliferation of niche entrants focusing on single attributes-such as enhanced breathability, antimicrobial finishes, or recyclable materials-has expanded the breadth of available options and complicated the clinical evaluation process. Suppliers capable of demonstrating robust quality systems, traceability across the supply chain, and rigorous third-party testing gain a competitive edge in procurement evaluations that prioritize risk mitigation and regulatory compliance.

For commercial leaders, differentiation increasingly relies on bundled services, clinical training, and total lifecycle accountability rather than on price alone. These capabilities enable closer alignment with institutional quality goals, reduce adoption friction, and support longer-term contracting relationships that balance cost, performance, and continuity.

Actionable recommendations for manufacturers, procurers, and clinical leaders to balance innovation, sourcing resilience, and lifecycle stewardship for surgical gowns

To remain resilient and clinically aligned, industry leaders should pursue a multi-pronged strategy that balances innovation, supply continuity, and lifecycle stewardship. First, invest in product development that prioritizes proven barrier performance, ergonomic fit, and material choices that reduce environmental impact without compromising clinical protection. Second, diversify manufacturing and sourcing footprints to include regional capacities and qualified secondary suppliers, thereby mitigating the operational risk associated with geopolitical and tariff volatility.

Third, strengthen supplier-buyer relationships through outcome-focused contracts that include performance guarantees, agreed service levels, and mechanisms for rapid escalation during supply disruptions. Fourth, expand clinical engagement programs that facilitate hands-on evaluations and clinician feedback loops to accelerate adoption and ensure that product selection is informed by real-world usability data. Fifth, pursue lifecycle strategies that evaluate the total environmental and operational implications of disposable versus reusable options, including investments in sterilization and linen management where reusable solutions are adopted.

Finally, adopt greater transparency in supply chain documentation and quality data so that procurement decisions can be made with confidence. Executing these recommendations will support sustained clinical performance, reduce vulnerability to external shocks, and align product offerings with evolving institutional priorities for safety, sustainability, and cost efficiency.

A transparent mixed-methods research approach integrating primary interviews, standards review, and scenario testing to validate clinical and supply chain findings

This research synthesis is grounded in a hybrid methodology combining primary and secondary inquiry, rigorous document review, and cross-validation with clinical and supply chain stakeholders. Primary inputs included structured interviews with procurement leaders, sterile processing managers, clinician champions across surgical specialties, and manufacturing quality leads, providing direct insight into specification drivers, evaluation protocols, and logistical constraints. These discussions informed qualitative assessments of product adoption dynamics, clinical usability concerns, and supplier performance attributes.

Secondary analysis encompassed standards documentation, peer-reviewed literature on barrier performance and infection prevention, industry white papers on nonwoven technology and textile processing, and regulatory guidance relevant to surgical apparel. Triangulation of these sources ensured that conclusions reflect consensus across clinical practice, product performance evidence, and regulatory expectations. Throughout the research process, emphasis was placed on traceable sourcing, validation of test methods, and alignment between stated product claims and independent performance evaluations.

Finally, findings were stress-tested through scenario analysis to explore the operational implications of supply disruptions, tariff changes, and rapid shifts in clinical demand. This methodological approach supports robust, actionable insight while acknowledging areas where further primary data collection could yield deeper specialty-specific or regional granularity.

A strategic conclusion emphasizing the integrated clinical, operational, and sustainability implications that should guide future gown procurement and product development

In conclusion, surgical gowns are evolving beyond their traditional role as disposable protective layers into strategically significant products that intersect clinical safety, operational resilience, and environmental stewardship. Material innovation, tightened regulatory expectations, and supply chain realignments are collectively influencing procurement criteria and clinician preferences. As a result, organizations must adopt a holistic approach to gown selection that incorporates barrier performance, user comfort, lifecycle impact, and supplier reliability.

Decision-makers should prioritize transparent performance data, rigorous clinical evaluation, and contractual safeguards that protect continuity of supply while enabling access to innovation. By aligning procurement practices with clinical needs and operational realities, healthcare institutions can reduce procedural risk, enhance clinician satisfaction, and strengthen resilience against external disruptions. Continued collaboration among manufacturers, healthcare providers, and standards bodies will be essential to drive incremental improvements in product design, validation methods, and sustainable practices that meet the evolving demands of surgical care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Gown Market, by Product Type

  • 8.1. Disposable
  • 8.2. Reusable

9. Surgical Gown Market, by Sterility

  • 9.1. Non-Sterile
  • 9.2. Sterile

10. Surgical Gown Market, by Material

  • 10.1. Polyester-Cotton Blends
  • 10.2. Polyethylene-Coated Polypropylene
  • 10.3. Spunbond Polypropylene
  • 10.4. Spunbond-Meltblown-Spunbond

11. Surgical Gown Market, by Protection Level

  • 11.1. Level 1 (Minimal Risk)
  • 11.2. Level 2 (Low Risk)
  • 11.3. Level 3 (Moderate Risk)
  • 11.4. Level 4 (High Risk)

12. Surgical Gown Market, by Application

  • 12.1. Cardiovascular
  • 12.2. General Surgery
  • 12.3. Orthopedic

13. Surgical Gown Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Clinics
  • 13.3. Hospitals

14. Surgical Gown Market, by Distribution Channel

  • 14.1. Offline
  • 14.2. Online

15. Surgical Gown Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Surgical Gown Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Surgical Gown Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Surgical Gown Market

19. China Surgical Gown Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. 3M Company
  • 20.6. Ahlstrom-Munksjo Oyj
  • 20.7. ANSELL LTD
  • 20.8. B. Braun SE
  • 20.9. Cardinal Health, Inc.
  • 20.10. Delta Med S.p.A.
  • 20.11. Dispotech srl
  • 20.12. DuPont de Nemours, Inc.
  • 20.13. Halyard Health, Inc. by Owens & Minor Inc.
  • 20.14. Kimberly-Clark Corporation
  • 20.15. Lohmann & Rauscher GmbH & Co. KG
  • 20.16. Medica Europe B.V.
  • 20.17. Medline Industries, Inc.
  • 20.18. Molnlycke Health Care AB
  • 20.19. Paul Hartmann AG
  • 20.20. PRIMED Medical Products Inc.
  • 20.21. Priontex (Pty) Ltd
  • 20.22. Sara Health Care Pvt Ltd
  • 20.23. Shanghai Medical Corporation
  • 20.24. Steris Corporation
  • 20.25. Thermo Fisher Scientific Inc.
  • 20.26. TIDI Products, LLC
  • 20.27. Winner Medical Co., Ltd.
  • 20.28. Zhejiang Runtai Automation Technology Co.,Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL GOWN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL GOWN MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL GOWN MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL GOWN MARKET SIZE, BY STERILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL GOWN MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SURGICAL GOWN MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SURGICAL GOWN MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES SURGICAL GOWN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA SURGICAL GOWN MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL GOWN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL GOWN MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL GOWN MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL GOWN MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL GOWN MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL GOWN MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL GOWN MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL GOWN MARKET SIZE, BY NON-STERILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL GOWN MARKET SIZE, BY NON-STERILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL GOWN MARKET SIZE, BY NON-STERILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL GOWN MARKET SIZE, BY STERILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL GOWN MARKET SIZE, BY STERILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL GOWN MARKET SIZE, BY STERILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL GOWN MARKET SIZE, BY POLYESTER-COTTON BLENDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL GOWN MARKET SIZE, BY POLYESTER-COTTON BLENDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL GOWN MARKET SIZE, BY POLYESTER-COTTON BLENDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL GOWN MARKET SIZE, BY POLYETHYLENE-COATED POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL GOWN MARKET SIZE, BY POLYETHYLENE-COATED POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL GOWN MARKET SIZE, BY POLYETHYLENE-COATED POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL GOWN MARKET SIZE, BY SPUNBOND POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL GOWN MARKET SIZE, BY SPUNBOND POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL GOWN MARKET SIZE, BY SPUNBOND POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL GOWN MARKET SIZE, BY SPUNBOND-MELTBLOWN-SPUNBOND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL GOWN MARKET SIZE, BY SPUNBOND-MELTBLOWN-SPUNBOND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL GOWN MARKET SIZE, BY SPUNBOND-MELTBLOWN-SPUNBOND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 1 (MINIMAL RISK), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 1 (MINIMAL RISK), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 1 (MINIMAL RISK), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 2 (LOW RISK), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 2 (LOW RISK), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 2 (LOW RISK), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 3 (MODERATE RISK), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 3 (MODERATE RISK), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 3 (MODERATE RISK), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 4 (HIGH RISK), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 4 (HIGH RISK), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 4 (HIGH RISK), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL GOWN MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL GOWN MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL GOWN MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL GOWN MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL GOWN MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL GOWN MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL GOWN MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL GOWN MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL GOWN MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL GOWN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL GOWN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL GOWN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL GOWN MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL GOWN MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL GOWN MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL GOWN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL GOWN MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL GOWN MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL GOWN MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL GOWN MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL GOWN MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL GOWN MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL GOWN MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL GOWN MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL GOWN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS SURGICAL GOWN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL SURGICAL GOWN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. GCC SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. GCC SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 146. GCC SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 147. GCC SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 148. GCC SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. GCC SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. GCC SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. G7 SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. G7 SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. G7 SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 170. G7 SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 171. G7 SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 172. G7 SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. G7 SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. G7 SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. NATO SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. NATO SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. NATO SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 178. NATO SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 179. NATO SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 180. NATO SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. NATO SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. NATO SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES SURGICAL GOWN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA SURGICAL GOWN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)